Sanofi Rare Diseases Medical
MPS I
MPS I 101
An in-depth look at the epidemiology, inheritance, and pathophysiology of MPS I.
New to Molecular Testing?
This short video provides general education on molecular testing for healthcare providers who are unfamiliar with the process.
____________________________________________________________________________________________________________________________________
Diagnosis of MPS I
This brochure provides information on diagnosing MPS I, including a list of labs offering IDUA gene sequencing or α-L-iduronidase enzyme activity assay.
This is not an exhaustive list of labs, or an endorsement of any one lab. Other testing options can be found at https://www.concertgenetics.com (free login required) or https://www.ncbi.nlm.nih.gov/gtr. Sanofi does not review or control the content of non-Sanofi websites. These listings do not constitute an endorsement by Sanofi of information provided by any other organizations. Tests may not be available in all states. Please contact the laboratory to confirm test availability, sample shipping information, and all other logistics.
____________________________________________________________________________________________________________________________________
Recommended Minimum Evaluation Schedule
A list of recommendations on a minimum evaluation schedule obtained from peer-reviewed publications. Physicians and other healthcare providers will determine the assessments and their actual frequency according to the patient’s individual needs.
Sanofi does not review or control the content of non-Sanofi websites. These listings do not constitute an endorsement by Sanofi of information provided by any other organizations.
Concert Genetics (free login required)
____________________________________________________________________________________________________________________________________
MPS Society
____________________________________________________________________________________________________________________________________
National Organization for Rare Disorders
____________________________________________________________________________________________________________________________________
Genetic Home Reference
____________________________________________________________________________________________________________________________________
Sanofi Medical Information
____________________________________________________________________________________________________________________________________
Patient Registry
The goal of the MPS I Registry is to collect clinical data on people with MPS I disease around the world in an effort to foster better understanding of MPS I disease and its management. Specifically, the Registry tracks information on patient demographics, disease characteristics, treatment goals, and outcomes.
Within your individual practice, the Registry’s patient case report (PCR) section allows you to monitor each of your patient's disease progress and response to therapy. The reports graphically summarize the changes in clinical parameters, such as organ volume over time and responses to disease management.
For more information on The MPS I Registry, visit our website.